» Articles » PMID: 31136432

CORR Insights®: Postoperative Thromboprophylaxis With New Oral Anticoagulants is Superior to LMWH in Hip Arthroplasty Surgery: Findings from the Swedish Registry

Overview
Publisher Wolters Kluwer
Specialty Orthopedics
Date 2019 May 29
PMID 31136432
Authors
Affiliations
Soon will be listed here.
Citing Articles

Comparison between low molecular weight heparin and apixaban (direct oral anticoagulant) in the prophylaxis against venous thromboembolism after laparoscopic sleeve gastrectomy.

Abdelsalam A, Fikry M, Fahmy A, Hegazy T, Hamdy A, Refaat A Obes Surg. 2025; 35(3):934-940.

PMID: 39921824 PMC: 11906520. DOI: 10.1007/s11695-025-07721-y.

References
1.
Kim Y, Oh S, Kim J . Incidence and natural history of deep-vein thrombosis after total hip arthroplasty. A prospective and randomised clinical study. J Bone Joint Surg Br. 2003; 85(5):661-5. View

2.
Eriksson B, Dahl O, Rosencher N, Kurth A, van Dijk C, Frostick S . Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial. Lancet. 2007; 370(9591):949-56. DOI: 10.1016/S0140-6736(07)61445-7. View

3.
Eriksson B, Borris L, Friedman R, Haas S, Huisman M, Kakkar A . Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. N Engl J Med. 2008; 358(26):2765-75. DOI: 10.1056/NEJMoa0800374. View

4.
Kubitza D, Becka M, Mueck W, Halabi A, Maatouk H, Klause N . Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor. Br J Clin Pharmacol. 2010; 70(5):703-12. PMC: 2997310. DOI: 10.1111/j.1365-2125.2010.03753.x. View

5.
Lassen M, Gallus A, Raskob G, Pineo G, Chen D, Ramirez L . Apixaban versus enoxaparin for thromboprophylaxis after hip replacement. N Engl J Med. 2010; 363(26):2487-98. DOI: 10.1056/NEJMoa1006885. View